ID: ALA434819

Max Phase: Preclinical

Molecular Formula: C23H16O5

Molecular Weight: 372.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)c1ccc(C=C2c3cccc(O)c3C(=O)c3c(O)cccc32)cc1

Standard InChI:  InChI=1S/C23H16O5/c1-28-23(27)14-10-8-13(9-11-14)12-17-15-4-2-6-18(24)20(15)22(26)21-16(17)5-3-7-19(21)25/h2-12,24-25H,1H3

Standard InChI Key:  SSXZXOKSPXHWPG-UHFFFAOYSA-N

Associated Targets(non-human)

Arachidonate 5-lipoxygenase 259 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 372.38Molecular Weight (Monoisotopic): 372.0998AlogP: 4.02#Rotatable Bonds: 2
Polar Surface Area: 83.83Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.28CX Basic pKa: CX LogP: 5.93CX LogD: 5.87
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: 0.26

References

1. Müller K, Gürster D, Piwek S, Wiegrebe W..  (1993)  Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.,  36  (25): [PMID:8258834] [10.1021/jm00077a015]

Source